Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
32
datasets available to search
ShareScore release 0.9.0
Dataset results
32 results for “Clopidogrel Resistance”
Effect of Primidone on Platelet Responsiveness in Patients Determined to be Clopidogrel Resistant
ClinicalTrials.gov study NCT02008123. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prevalence of Clopidogrel (Plavix) Resistance in Hemodialysis Patients
ClinicalTrials.gov study NCT01865890. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biomarkers of Clopidogrel Resistance for Predicting Ischemic Recurrence After Cerebral Artery Stenting
ClinicalTrials.gov study NCT07028775. IPD Sharing: NO. Countries: 1. Publications: 0.
Ticagrelor and Clopidogrel on Platelet Aggregation in Clopidogrel Resistance's Patients With CHD
ClinicalTrials.gov study NCT03614832. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Thromboelastography As A Tool for Possible Clopidogrel Resistance in The Patients Treated With Primary PCI for STEMI
ClinicalTrials.gov study NCT00517478. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent Implantation
ClinicalTrials.gov study NCT01094457. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of RF on Clopidogrel Resistance in Patients at High Cardiovascular Risk
ClinicalTrials.gov study NCT02624583. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Resistance to Aspirin and/or Clopidogrel Among Patients With PAD.
ClinicalTrials.gov study NCT00262561. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clopidogrel Resistance in Stroke Patients From Different Ethnicities
ClinicalTrials.gov study NCT03806894. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Evaluation of the Efficacy of Novel Biomarkers in Predicting Clopidogrel Resistance in Patients with Ischemic Stroke
ClinicalTrials.gov study NCT06753149. IPD Sharing: NO. Countries: 0. Publications: 0.
Clopidogrel Resistance and the Possibility of Its Affection
ClinicalTrials.gov study NCT00839345. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clopidogrel Resistance and Ticagrelor Replacement in Dual Antiplatelet Therapy for Carotid Artery Stenting
<p>Mazzaccaro D, Giannetta M, Ranucci M, Righini P, Di Dedda U, Baryshnikova E, Milani V, Nano G. Clopidogrel Resistance and Ticagrelor Replacement in Dual Antiplatelet Therapy for Carotid Artery Stenting. Ann Vasc Surg. 2022 Oct 19:S0890-5096(22)00640-9. doi: 10.1016/j.avsg.2022.09.063. Epub ahead of print. PMID: 36270550.</p> <p>Abstract</p> <p><strong>Backgrounds: </strong>Resistance to the pharmacological effect of clopidogrel in patients undergoing dual antiplatelet therapy for carotid stenting may increase the risk of periprocedural neurological events. The purpose of the study was to describe the phenomenon of clopidogrel resistance in a series of patients undergoing carotid stenting.</p> <p><strong>Methods: </strong>Data of patients who consecutively underwent carotid stenting from November 2016 to December 2020 for a significant stenosis and who underwent a dual antiplatelet therapy using acetyl-salicylic acid and clopidogrel were prospectively collected. Patients who were already taking a different thienopyridine were excluded. The effectiveness of antiplatelet drugs was assessed by the impedance aggregometry test. Primary endpoint was to evaluate the incidence of clopidogrel resistance and the effectiveness of ticagrelor as alternative therapy. P values < 0.05 were considered statistically significant.</p> <p><strong>Results: </strong>Two-hundred patients (80 females, 40%) underwent stenting for carotid stenosis (94% asymptomatic). The phenomenon of clopidogrel resistance was observed in 38 patients (19%), in whom clopidogrel was replaced by ticagrelor (90 mg/bis in die) with 100% effectiveness at aggregometry test. Platelet counts was associated to clopidogrel resistance (P = 0.001). There was no stent thrombosis at 30 days, neither major hemorrhagic events; a total of 12/200 major adverse cardiovascular events occurred (6%), including 1 in the group of patients who took ticagrelor and 11 in group of patients under clopidogrel (2.6% versus 6.7%, P = 0.55).</p> <p><strong>Conclusions: </strong>Clopidogrel was ineffective in 19% of patients undergoing carotid stenting. Platelet count seemed to affect this phenomenon. In these patients, clopidogrel was effectively replaced by ticagrelor.</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.